NexgenRx Stock Price

TSXV:NXGCA$19.9mInsurance

NXG Share Price Performance

NXG Community Fair Values

Your Fair Value
CA$
Current Price
CA$0.2817.6% undervalued intrinsic discount
Growth estimate over
Annual revenue growth rate
%/yr
Decrease
Increase
Advanced

View all narratives

Recent NXG News & Updates

Pinning Down NexgenRx Inc.'s (CVE:NXG) P/S Is Difficult Right Now

Apr 07

NexgenRx Inc. Competitors

View more competitors

NexgenRx Inc. Key Details

Last Reported Earnings

Mar 31, 2025

Yearly revenue growth

n/a

Earnings per share (EPS): 0.0068
Gross Margin: 79.34%
Net Profit Margin: 2.87%
Debt/Equity Ratio: 0%

View full report ›

Canadian Market Performance

7 Days: 0.4%
3 Months: 10.0%
1 Year: 16.5%
Year to Date: 6.2%

The market has been flat over the last week. As for the longer term, the market has risen 16% in the past 12 months. Looking forward, earnings are forecast to grow by 13% annually. Market details ›

🚀 Finding Moonshots in the Space Race

Richard Bowman

June 2025

The Space industry has a massive runway ahead of it, so it’s worth getting to know it if you are a long-term investor. We figured now would be a great time to check in on the industry!

Last Week

NexgenRx Stock Price

NXG Share Price Performance

NXG Community Fair Values

Recent NXG News & Updates

Nexgenrx Inc. Declares Dividend on Common Shares, Payable on or before April 30, 2025

Pinning Down NexgenRx Inc.'s (CVE:NXG) P/S Is Difficult Right Now

NexgenRx Inc., Annual General Meeting, May 15, 2025

Dividend of CA$0.005 announced

Nexgenrx Inc. Declares Dividend on Common Shares, Payable on or Before December 20, 2024

Third quarter 2024 earnings released: EPS: CA$0.002 (vs CA$0.002 loss in 3Q 2023)

NexgenRx Inc. Announces Appointment of Linda Brennan to Its Board of Directors

New major risk - Revenue and earnings growth

NexgenRx Inc. Competitors

🚀 Finding Moonshots in the Space Race

🎢 Opportunities In The Turbulent Transition To Greener Energy